Issue 16, 2018

Carbonate esters turn camptothecin-unsaturated fatty acid prodrugs into nanomedicines for cancer therapy

Abstract

We report that carbonate esters could turn hydrophobic camptothecin (CPT)-unsaturated fatty acid prodrugs into nanoaggregates in aqueous solution. The active CPT could be rapidly released once triggered by a reductive stimulus when a carbonate ester was combined with a disulfide bond, resulting in a potent in vivo antitumor activity.

Graphical abstract: Carbonate esters turn camptothecin-unsaturated fatty acid prodrugs into nanomedicines for cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
25 Jan 2018
Accepted
29 Jan 2018
First published
29 Jan 2018

Chem. Commun., 2018,54, 1996-1999

Carbonate esters turn camptothecin-unsaturated fatty acid prodrugs into nanomedicines for cancer therapy

Y. Li, T. Kang, Y. Wu, Y. Chen, J. Zhu and M. Gou, Chem. Commun., 2018, 54, 1996 DOI: 10.1039/C8CC00639C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements